Unique Ingredient Identifier LKG8494WBH is listed as a ingredient substance
| RN | 100-51-6 |
| EC | 202-859-9 |
| NCIT | C77028 |
| RXCUI | 1426 |
| PUBCHEM | 244 |
| INN ID | 923 |
| MF | C7H8O |
| INCHI KEY | WVDDGKGOMKODPV-UHFFFAOYSA-N |
| SMILES | OCC1=CC=CC=C1 |
UNII LKG8494WBH BENZYL ALCOHOL is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | NA |
| AURICULAR (OTIC) | SUSPENSION | NA |
| AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.9 % |
| DENTAL | PASTE | 25 MG |
| EPIDURAL | INJECTION | 1 % |
| EXTRACORPOREAL | INJECTION | 1 % |
| IM - IV | INJECTABLE | 1 % |
| IM - IV | INJECTION | 9.45 MG/1ML |
| IM - IV | INJECTION | 5.21 % |
| IM - IV | LIQUID, WATER, STERILE, FOR INJECTION | 1 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 6.69 % |
| IM - IV | SOLUTION, INJECTION | 2 % |
| IM - IV - SC | INJECTION | 1.8 % |
| IM - SC | INJECTABLE | 1.2 % |
| IM - SC | INJECTION | 2 % |
| IM - SC | INJECTION, SUSTAINED ACTION | 1.2 % |
| INTERSTITIAL | INJECTION | NA |
| INTRA-ARTERIAL | INJECTION | 0.9 % |
| INTRA-ARTERIAL | SUSPENSION, INJECTION | 9.16 mg/1mL |
| INTRA-ARTICULAR | INJECTABLE | 0.94 % |
| INTRA-ARTICULAR | INJECTION | 9.9 MG/1ML |
| INTRA-ARTICULAR | INJECTION | 1.5 % |
| INTRA-ARTICULAR | INJECTION, SOLUTION | 10 mg/1mL |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRABURSAL | INJECTION | 1 % |
| INTRACAVITARY | INJECTION | NA |
| INTRACAVITARY | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.84 % |
| INTRADERMAL | INJECTION | 0.9 % |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | INJECTABLE | 0.94 % |
| INTRALESIONAL | INJECTION | 1 % |
| INTRALESIONAL | INJECTION, SOLUTION | 9 MG/1ML |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | SUSPENSION, INJECTION | 9.16 mg/1mL |
| INTRALESIONAL | SUSPENSION, INJECTION | 0.92 % |
| INTRAMUSCULAR | INJECTABLE | 5.71 %W/V |
| INTRAMUSCULAR | INJECTION | 12 mg/1mL |
| INTRAMUSCULAR | INJECTION | 10.96 %W/V |
| INTRAMUSCULAR | INJECTION | 0.1 mL/1mL |
| INTRAMUSCULAR | INJECTION, MICROSPHERES | NA |
| INTRAMUSCULAR | INJECTION, SOLUTION | 10 mg/1mL |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | 1 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.9 % |
| INTRAMUSCULAR | SOLUTION | 2 %W/V |
| INTRAMUSCULAR | SOLUTION, INJECTION | 10 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 9.16 mg/1mL |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.92 %W/V |
| INTRAPERITONEAL | INJECTION | NA |
| INTRAPLEURAL | INJECTION | NA |
| INTRASYNOVIAL | INJECTABLE | 0.92 % |
| INTRASYNOVIAL | INJECTION | 1 % |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
| INTRASYNOVIAL | SUSPENSION, INJECTION | 0.92 % |
| INTRA-SYNOVIAL | SUSPENSION, INJECTION | 9.16 mg/1mL |
| INTRATHECAL | INJECTION | 0.45 % |
| INTRATRACHEAL | SUSPENSION | NA |
| INTRATUMOR | INJECTION | 0.9 % |
| INTRAVENOUS | EMULSION, INJECTION | 0.4 % |
| INTRAVENOUS | INFUSION | 18 % |
| INTRAVENOUS | INJECTABLE | 2.02 % |
| INTRAVENOUS | INJECTION | 10.4 MG/1ML |
| INTRAVENOUS | INJECTION | 2 % |
| INTRAVENOUS | INJECTION, SOLUTION | 10 mg/1mL |
| INTRAVENOUS | LIQUID | 10.4 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 1.8 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 0.5 % |
| INTRAVENOUS | SOLUTION | 0.9 % |
| INTRAVENOUS | SOLUTION, INJECTION | 2.02 % |
| IV - SC | SOLUTION, INJECTION | 0.95 % |
| IV(INFUSION) | INJECTION | 30 MG/1ML |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 6.69 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 0.5 % |
| IV(INFUSION) | SOLUTION | 2.02 % |
| IV(INFUSION) | SOLUTION, INJECTION | 2.02 % |
| NASAL | SPRAY | 0.9 % |
| NASAL | SPRAY, METERED | 0.5 % |
| NERVE BLOCK | INJECTION | NA |
| OPHTHALMIC | SUSPENSION | NA |
| ORAL | CAPSULE | 15 MG |
| ORAL | CAPSULE, SOFT GELATIN | NA |
| ORAL | CAPSULE, SUSTAINED ACTION | 1.23 MG |
| ORAL | CONCENTRATE | NA |
| ORAL | SOLUTION | 50 MG/1ML |
| ORAL | SUSPENSION | 100 MG/10ML |
| ORAL | SUSPENSION | 52.35 mg/5mL |
| ORAL | SUSPENSION | 10.1 mg/1mL |
| ORAL | TABLET | 1.06 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 2.31 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 1.25 MG |
| RECTAL | GEL | 3.1 % |
| SOFT TISSUE | INJECTABLE | 0.94 % |
| SOFT TISSUE | INJECTION | 1 % |
| SOFT TISSUE | INJECTION, SUSTAINED ACTION | NA |
| SOFT TISSUE | SUSPENSION, INJECTION | 9.16 mg/1mL |
| SOFT TISSUE | SUSPENSION, INJECTION | 0.92 % |
| SUBCONJUNCTIVAL | INJECTION | 0.95 % |
| SUBCUTANEOUS | INJECTION | 12 MG/1ML |
| SUBCUTANEOUS | INJECTION | 4.5 % |
| SUBCUTANEOUS | LIQUID | 0.23 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 1.46 % |
| TOPICAL | CREAM | 2.7 %W/W |
| TOPICAL | CREAM, AUGMENTED | 1 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 2 %W/W |
| TOPICAL | EMULSION, CREAM | 2.7 %W/W |
| TOPICAL | GEL | 2 %W/W |
| TOPICAL | LOTION | 1.3 %W/W |
| TOPICAL | OINTMENT | 2.2 %W/W |
| TOPICAL | SOLUTION | 2 %W/W |
| TOPICAL | SUPPOSITORY, INSERT | NA |
| TOPICAL | SUSPENSION | 1 %W/W |
| TOPICAL | TABLET | NA |
| URETERAL | SOLUTION | NA |
| VAGINAL | CREAM, AUGMENTED | 1 % |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 1 % |
| VAGINAL | EMULSION, CREAM | 1 % |
| VAGINAL | SUPPOSITORY, INSERT | NA |
| VAGINAL | TABLET | NA |